References
- Puomila A, Hamalainen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15(10):1079–1089. doi:https://doi.org/10.1038/sj.ejhg.5201828.
- Yu-Wai-Man P, Griffiths PG, Brown DT, et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2):333–339. doi:https://doi.org/10.1086/346066.
- Orphanet. Leber’s Hereditary Optic Neuropathy.
- Stenton SL, Sheremet NL, Catarino CB, et al. Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy. J Clin Invest. 2021;131(6). doi:https://doi.org/10.1172/JCI138267.
- Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet. 1997;60:381–387.
- Torroni A, Petrozzi M, D’Urbano L, et al. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet. 1997;60(5):1107–1121.
- Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet. 1995;57:77–86.
- Hudson G, Keers S, Yu-Wai-Man P, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet. 2005;77(6):1086–1091. doi:https://doi.org/10.1086/498176.
- Yu-Wai-Man P. Therapeutic approaches to inherited optic neuropathies. Semin Neurol. 2015;35(5):578–586. doi:https://doi.org/10.1055/s-0035-1563574.
- Moon Y, Kim US, Han J, et al. Clinical and Optic Disc Characteristics of Patients Showing Visual Recovery in Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2020;40(1):15–21. doi:https://doi.org/10.1097/WNO.0000000000000830.
- Kirkman MA, Korsten A, Leonhardt M, et al. Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50(7):3112–3115. doi:https://doi.org/10.1167/iovs.08-3166.
- Orssaud C. Cardiac disorders in patients with leber hereditary optic neuropathy. J Neuroophthalmol. 2018;38(4):466–469. doi:https://doi.org/10.1097/WNO.0000000000000623.
- Pfeffer G, Burke A, Yu-Wai-Man P, et al. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology. 2013;81(24):2073–2081. doi:https://doi.org/10.1212/01.wnl.0000437308.22603.43.
- Kim IS, Ki CS, Park KJ. Pediatric-onset dystonia associated with bilateral striatal necrosis and G14459A mutation in a Korean family: a case report. J Korean Med Sci. 2010;25(1):180–184. doi:https://doi.org/10.3346/jkms.2010.25.1.180.
- Novotny EJ, Singh G, Wallace DC, et al. Leber’s disease and dystonia. Neurology. 1986;36(8):1053. doi:https://doi.org/10.1212/WNL.36.8.1053.
- Cui S, Yang L, Jiang H, et al. Clinical features of Chinese sporadic leber hereditary optic neuropathy caused by rare primary mtDNA mutations. J Neuroophthalmol. 2020;40(1):30–36. doi:https://doi.org/10.1097/WNO.0000000000000799.
- Brandon MC, Lott MT, Nguyen KC, et al. MITOMAP: a human mitochondrial genome database–2004 update. Nucleic Acids Res. 2005;33( Database issue):D611–3. doi:https://doi.org/10.1093/nar/gki079.
- Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59(2):481–485.
- Johns DR, Heher KL, Miller NR, Smith KH. Leber’s hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol. 1993;111(4):495–498. doi:https://doi.org/10.1001/archopht.1993.01090040087038.
- Johns DR, Smith KH, Miller NR. Leber’s hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol. 1992;110(11):1577–1581. doi:https://doi.org/10.1001/archopht.1992.01080230077025.
- Burte F, Carelli V, Chinnery PF, Yu-Wai-Man P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol. 2015;11(1):11–24. doi:https://doi.org/10.1038/nrneurol.2014.228.
- Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81–114. doi:https://doi.org/10.1016/j.preteyeres.2010.11.002.
- Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165–1176. doi:https://doi.org/10.2147/OPTH.S62021.
- La Morgia C, Ross-Cisneros FN, Sadun AA, et al. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain. 2010;133(Pt 8):2426–2438. doi:https://doi.org/10.1093/brain/awq155.
- Giordano C, Iommarini L, Giordano L, et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber’s hereditary optic neuropathy. Brain. 2014;137(Pt 2):335–353. doi:https://doi.org/10.1093/brain/awt343.
- Hedges TR, Gobuty M, Manfready RA, et al. The optical coherence tomographic profile of leber hereditary optic neuropathy. Neuroophthalmology. 2016;40(3):107–112. doi:https://doi.org/10.3109/01658107.2016.1173709.
- Day AC, Donachie PH, Sparrow JM, Johnston RL. The Royal College of ophthalmologists’ national ophthalmology database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29(4):552–560. doi:https://doi.org/10.1038/eye.2015.3.
- Sutherland JE, Day MA. Advantages and disadvantages of molecular testing in ophthalmology. Expert Rev Ophthalmol. 2011;6(2):221–245. doi:https://doi.org/10.1586/eop.11.2.
- Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain. 2011;134(Pt 9):2677–2686. doi:https://doi.org/10.1093/brain/awr170.
- Central Statistics Office C, Ireland. 2016 Census of Population.
- Vaphiades MS, Newman NJ. Optic nerve enhancement on orbital magnetic resonance imaging in Leber’s hereditary optic neuropathy. J Neuroophthalmol. 1999;19(4):238–239. doi:https://doi.org/10.1097/00041327-199912000-00006.
- van Westen D, Hammar B, Bynke G. Magnetic resonance findings in the pregeniculate visual pathways in Leber hereditary optic neuropathy. J Neuroophthalmol. 2011;31(1):48–51. doi:https://doi.org/10.1097/WNO.0b013e3181f3f203.
- Yu-Wai-Man P, Howell N, Mackey DA, et al. Mitochondrial DNA haplogroup distribution within Leber hereditary optic neuropathy pedigrees. J Med Genet. 2004;41(4):e41. doi:https://doi.org/10.1136/jmg.2003.011247.
- Brown MD, Trounce IA, Jun AS, et al. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber’s hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem. 2000;275(51):39831–39836. doi:https://doi.org/10.1074/jbc.M006476200.
- Lacy GD, Abalem MF, Musch DC, Jayasundera KT. Patient-reported outcome measures in inherited retinal degeneration gene therapy trials. Ophthalmic Genet. 2020;41(1):1–6. doi:https://doi.org/10.1080/13816810.2020.1731836.
- Savini G, Barboni P, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber’s hereditary optic neuropathy mutations. Ophthalmology. 2005;112(1):127–131. doi:https://doi.org/10.1016/j.ophtha.2004.09.033.
- Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132(Pt 9):2317–2326. doi:https://doi.org/10.1093/brain/awp158.
- Chinnery PF, Andrews RM, Turnbull DM, Howell NN. Leber hereditary optic neuropathy: does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? Am J Med Genet. 2001;98(3):235–243. doi:https://doi.org/10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O.
- Hyslop LA, Blakeley P, Craven L, et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature. 2016;534(7607):383–386. doi:https://doi.org/10.1038/nature18303.
- Michelessi M, Li T, and Miele A, et al. Accuracy of optical coherence tomography for diagnosing glaucoma: an overview of systematic reviews. Br J Ophthalmol. 2021;105:490-495.
- Moster SJ, Moster ML, Scannell Bryan M, Sergott RC. Retinal ganglion cell and inner plexiform layer loss correlate with visual acuity loss in LHON: a longitudinal, segmentation OCT analysis. Invest Ophthalmol Vis Sci. 2016;57(8):3872–3883. doi:https://doi.org/10.1167/iovs.15-17328.
- Barboni P, Savini G, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy. Ophthalmology. 2005;112(1):120–126. doi:https://doi.org/10.1016/j.ophtha.2004.06.034.
- Orssaud C, Roche O, Dufier JL. Nutritional optic neuropathies. J Neurol Sci. 2007;262(1–2):158–164. doi:https://doi.org/10.1016/j.jns.2007.06.038.
- Theodorou-Kanakari A, Karampitianis S, Karageorgou V, et al. Current and emerging treatment modalities for leber’s hereditary optic neuropathy: a review of the literature. Adv Ther. 2018;35(10):1510–1518. doi:https://doi.org/10.1007/s12325-018-0776-z.
- Leruez S, Verny C, Bonneau D, et al. Cyclosporine A does not prevent second-eye involvement in Leber’s hereditary optic neuropathy. Orphanet J Rare Dis. 2018;13(1):33. doi:https://doi.org/10.1186/s13023-018-0773-y.
- Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain. 2011;134(Pt 1):220–234. doi:https://doi.org/10.1093/brain/awq276.
- La Morgia C, Carbonelli M, Barboni P, et al. Medical management of hereditary optic neuropathies. Front Neurol. 2014;5:141. doi:https://doi.org/10.3389/fneur.2014.00141.
- Carelli V, Carbonelli M, de Coo IF, et al. International consensus statement on the clinical and therapeutic management of leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37(4):371–381. doi:https://doi.org/10.1097/WNO.0000000000000570.
- Saini R. Coenzyme Q10: the essential nutrient. J Pharm Bioallied Sci. 2011;3(3):466–467. doi:https://doi.org/10.4103/0975-7406.84471.
- Haefeli RH, Erb M, Gemperli AC, et al. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One. 2011;6(3):e17963. doi:https://doi.org/10.1371/journal.pone.0017963.
- Sadun AA, Chicani CF, Ross-Cisneros FN, et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol. 2012;69(3):331–338. doi:https://doi.org/10.1001/archneurol.2011.2972.
- Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy. Brain. 2013;136(Pt 2):e230. doi:https://doi.org/10.1093/brain/aws279.
- Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber’s hereditary optic neuropathy. Brain. 2011;134(Pt 9):e188. doi:https://doi.org/10.1093/brain/awr180.
- Koilkonda RD, Yu H, Chou TH, et al. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132(4):409–420. doi:https://doi.org/10.1001/jamaophthalmol.2013.7630.
- Yu-Wai-Man P, Newman NJ, Carelli V, et al. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med. 2020;12(573). doi:https://doi.org/10.1126/scitranslmed.aaz7423.
- Wan X, Pei H, Zhao MJ, et al. Efficacy and safety of rAAV2-ND4 treatment for leber’s hereditary optic neuropathy. Sci Rep. 2016;6:21587. doi:https://doi.org/10.1038/srep21587.
- Johnson TV, Martin KR. Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13(1):78–82. doi:https://doi.org/10.1016/j.coph.2012.08.003.
- Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber’s hereditary optic neuropathy. Neural Regen Res. 2016;11(10):1685–1694. doi:https://doi.org/10.4103/1673-5374.193251.
- Smith KH, Johns DR, Heher KL, Miller NR. Heteroplasmy in Leber’s hereditary optic neuropathy. Arch Ophthalmol. 1993;111(11):1486–1490. doi:https://doi.org/10.1001/archopht.1993.01090110052022.
- Lott MT, Voljavec AS, Wallace DC. Variable genotype of Leber’s hereditary optic neuropathy patients. Am J Ophthalmol. 1990;109(6):625–631. doi:https://doi.org/10.1016/S0002-9394(14)72429-8.
- Howell N, Xu M, Halvorson S, et al. A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. Am J Hum Genet. 1994;55(1):203–206.
- Huoponen K, Puomila A, Savontaus ML, et al. Genetic counseling in Leber hereditary optic neuropathy (LHON). Acta Ophthalmol Scand. 2002;80(1):38–43. doi:https://doi.org/10.1034/j.1600-0420.2002.800108.x.
- Elliott HR, Samuels DC, Eden JA, et al. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet. 2008;83(2):254–260. doi:https://doi.org/10.1016/j.ajhg.2008.07.004.
- Irish Road Safety Authority. Medical aspects of driver licensing: a guide for registered medical practitioners 2010. 2010.
- Hepworth LR, Rowe FJ, Burnside G. Development of a patient reported outcome measures for measuring the impact of visual impairment following stroke. BMC Health Serv Res. 2019;19(1):348. doi:https://doi.org/10.1186/s12913-019-4157-3.